Paying users zone. Data is covered by .

• Get to Bristol-Myers Squibb Co. for \$17.99, or

• get to whole website for at least 3 months from \$49.99.

# Bristol-Myers Squibb Co. (BMY)

## Dividend Discount Model (DDM)

Difficulty: Intermediate

In discounted cash flow (DCF) valuation techniques the value of the stock is estimated based upon present value of some measure of cash flow. Dividends are the cleanest and most straightforward measure of cash flow because these are clearly cash flows that go directly to the investor.

### Intrinsic Stock Value (Valuation Summary)

Bristol-Myers Squibb Co., dividends per share (DPS) forecast

USD \$

Year Value DPSt or Terminal value (TVt) Calculation Present value at %
0 DPS01
1 DPS1 = × (1 + %)
2 DPS2 = × (1 + %)
3 DPS3 = × (1 + %)
4 DPS4 = × (1 + %)
5 DPS5 = × (1 + %)
5 Terminal value (TV5) = × (1 + %) ÷ (% – %)
Intrinsic value of BMS's common stock (per share) \$
Current share price \$

1 DPS0 = Sum of last year dividends per share of BMS's common stock. See details »

Disclaimer!
Valuation is based on standard assumptions. There may exist specific factors relevant to stock value and omitted here. In such a case, the real stock value may differ significantly form the estimated. If you want to use the estimated intrinsic stock value in investment decision making process, do so at your own risk.

Top

### Required Rate of Return (r)

 Assumptions Rate of return on LT Treasury Composite1 RF % Expected rate of return on market portfolio2 E(RM) % Systematic risk (β) of BMS's common stock βBMY Required rate of return on BMS's common stock3 rBMY %

1 Unweighted average of bid yields on all outstanding fixed-coupon U.S. Treasury bonds neither due or callable in less than 10 years (risk-free rate of return proxy).

Calculations

3 rBMY = RF + βBMY [E(RM) – RF]
= % + [% – %]
= %

Top

### Dividend Growth Rate (g)

#### Dividend growth rate (g) implied by PRAT model

Bristol-Myers Squibb Co., PRAT model

Average Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD \$ in millions)
Cash dividends
Net earnings attributable to BMS
Revenues
Total assets
Total Bristol-Myers Squibb Company shareholders' equity
Ratios
Retention rate1
Profit margin2 % % % % %
Asset turnover3
Financial leverage4
Averages
Retention rate
Profit margin %
Asset turnover
Financial leverage
Dividend growth rate (g)5 %

2017 Calculations

1 Retention rate = (Net earnings attributable to BMS – Cash dividends) ÷ Net earnings attributable to BMS
= () ÷ =

2 Profit margin = 100 × Net earnings attributable to BMS ÷ Revenues
= 100 × ÷ = %

3 Asset turnover = Revenues ÷ Total assets
= ÷ =

4 Financial leverage = Total assets ÷ Total Bristol-Myers Squibb Company shareholders' equity
= ÷ =

5 g = Retention rate × Profit margin × Asset turnover × Financial leverage
= × % × × = %

Top

#### Dividend growth rate (g) implied by Gordon growth model

g = 100 × (P0 × rD0) ÷ (P0 + D0)
= 100 × (\$ × % – \$) ÷ (\$ + \$) = %

where:
P0 = current price of share of BMS's common stock
D0 = last year dividends per share of BMS's common stock
r = required rate of return on BMS's common stock

Top

#### Dividend growth rate (g) forecast

Bristol-Myers Squibb Co., H-model

Year Value gt
1 g1 %
2 g2 %
3 g3 %
4 g4 %
5 and thereafter g5 %

where:
g1 is implied by PRAT model
g5 is implied by Gordon growth model
g2, g3 and g4 are calculated using linear interpoltion between g1 and g5

Calculations

g2 = g1 + (g5g1) × (2 – 1) ÷ (5 – 1)
= % + (% – %) × (2 – 1) ÷ (5 – 1) = %

g3 = g1 + (g5g1) × (3 – 1) ÷ (5 – 1)
= % + (% – %) × (3 – 1) ÷ (5 – 1) = %

g4 = g1 + (g5g1) × (4 – 1) ÷ (5 – 1)
= % + (% – %) × (4 – 1) ÷ (5 – 1) = %

Top